Kristin M. Bompiani

Development of universal antidotes to control aptamer activity

Sabah Oney, Ruby T. S. Lam, Kristin M. Bompiani et al. · Nature Medicine · 2009 · 121 citations · Full text

Medicine, Pharmacotherapy, Aptamer Activity +4

Conformationally selective RNA aptamers allosterically modulate the β2-adrenoceptor

Alem W. Kahsai, James W. Wisler, Jungmin Lee et al. · Nature Chemical Biology · 2016 · 80 citations · Full text

Selective Rna Aptamers, Natural Sciences, Rna Structure Prediction +3

Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass

Ruwan Gunaratne, Shekhar Kumar, James W. Frederiksen et al. · Nature Biotechnology · 2018 · 71 citations · Full text

Thrombosis, Cardiac Anaesthesia, Cardiovascular Disease +7

Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity

Kristin M. Bompiani, Cheng‐Yu Tsai, Felix P. Achatz et al. · Metallomics · 2016 · 70 citations · Full text

Cisplatin Sensitivity, Oncogenic Agent, Copper Transporters +14

A high affinity, antidote‐controllable prothrombin and thrombin‐binding RNA aptamer inhibits thrombin generation and thrombin activity

Kristin M. Bompiani, Dougald M. Monroe, Frank Church et al. · Journal of Thrombosis and Haemostasis · 2012 · 69 citations · Full text

Thrombosis, Rna Processing, Systems Biology +11